We identified Rgs1 as a novel candidate gene in atherosclerosis and AAA, and tested the hypothesis that RGS1 is a key modulator of chemokine receptor activity, with critical roles in regulating the vascular inflammatory response by affecting macrophage function. The gene discussed is RGS1; the disease is atherosclerosis.